Get started
333

GENOME&COMPANY

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

314130 chart


Full chart

Key stats


Market capitalization
‪86.72 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1,330 KRW
Net income (FY)
‪−47.47 B‬ KRW
Revenue (FY)
‪14.30 B‬ KRW
Shares float
‪19.03 M‬
Beta (1Y)
0.93

Employees


Employees (FY)
99
Change (1Y)
−9 −8.33%
Revenue / Employee (1Y)
‪110.90 K‬ KRW
Net income / Employee (1Y)
‪−368.22 K‬ KRW

About GENOME&COMPANY


Sector
Health Technology
Headquarters
Seongnam-si
Founded
2015
Website
genomecom.co.kr
ISIN
KR7314130006
FIGI
BBG00MV6YMQ9
Genome & Co. engages in research and development of dietary supplements, cosmeceuticals, and new drugs utilizing human microbiome. The company was founded by Ji-Soo Bae and Han-Su Park on September 24, 2015 and is headquartered in Seongnam-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 314130 is 2,915 KRW — it has increased by 3.57% in the past 24 hours. Watch GENOME&COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENOME&COMPANY stocks are traded under the ticker 314130.
314130 stock has fallen by −4.92% compared to the previous week, the month change is a −27.86% fall, over the last year GENOME&COMPANY has showed a −54.98% decrease.
314130 reached its all-time high on Dec 23, 2020 with the price of 47,500 KRW, and its all-time low was 2,710 KRW and was reached on Nov 15, 2024. View more price dynamics on 314130 chart.
See other stocks reaching their highest and lowest prices.
314130 stock is 3.35% volatile and has beta coefficient of 0.93. Track GENOME&COMPANY stock price on the chart and check out the list of the most volatile stocks — is GENOME&COMPANY there?
Today GENOME&COMPANY has the market capitalization of ‪86.72 B‬, it has decreased by −4.44% over the last week.
Yes, you can track GENOME&COMPANY financials in yearly and quarterly reports right on TradingView.
314130 net income for the last quarter is ‪−6.79 B‬ KRW, while the quarter before that showed ‪1.59 B‬ KRW of net income which accounts for −525.84% change. Track more GENOME&COMPANY financial stats to get the full picture.
No, 314130 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 99.00 employees. See our rating of the largest employees — is GENOME&COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOME&COMPANY EBITDA is ‪−32.13 B‬ KRW, and current EBITDA margin is −335.59%. See more stats in GENOME&COMPANY financial statements.
Like other stocks, 314130 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOME&COMPANY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOME&COMPANY technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOME&COMPANY stock shows the sell signal. See more of GENOME&COMPANY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.